Charles Schwab’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18M Sell
234,288
-17,341
-7% -$1.35M ﹤0.01% 1798
2025
Q4
$19.9M Buy
251,629
+15,968
+7% +$1.38M ﹤0.01% 1753
2025
Q3
$21.6M Sell
235,661
-21,981
-9% -$1.79M ﹤0.01% 1692
2025
Q2
$16.8M Buy
257,642
+19,265
+8% +$1.25M ﹤0.01% 1768
2025
Q1
$16M Buy
238,377
+2,220
+0.9% +$133K ﹤0.01% 1746
2024
Q4
$13.1M Sell
236,157
-14,189
-6% -$815K ﹤0.01% 1895
2024
Q3
$14.9M Buy
250,346
+8,869
+4% +$541K ﹤0.01% 1852
2024
Q2
$15.4M Buy
241,477
+44,994
+23% +$2.92M ﹤0.01% 1823
2024
Q1
$13.6M Buy
196,483
+49,431
+34% +$2.98M ﹤0.01% 1827
2023
Q4
$8.11M Buy
147,052
+63
+0% +$3.47K ﹤0.01% 2097
2023
Q3
$8.53M Buy
146,989
+109,015
+287% +$6.29M ﹤0.01% 1992
2023
Q2
$2.04M Buy
37,974
+2,935
+8% +$130K ﹤0.01% 2544
2023
Q1
$1.39M Buy
35,039
+384
+1% +$16.2K ﹤0.01% 2623
2022
Q4
$1.39M Buy
34,655
+1,371
+4% +$51.5K ﹤0.01% 2668
2022
Q3
$1.07M Buy
33,284
+612
+2% +$20.9K ﹤0.01% 2772
2022
Q2
$970K Buy
32,672
+3,477
+12% +$100K ﹤0.01% 2811
2022
Q1
$821K Buy
29,195
+590
+2% +$22K ﹤0.01% 2925
2021
Q4
$1.32M Buy
28,605
+4,165
+17% +$179K ﹤0.01% 2809
2021
Q3
$802K Sell
24,440
-44,853
-65% -$1.39M ﹤0.01% 2958
2021
Q2
$2.43M Buy
69,293
+9,951
+17% +$339K ﹤0.01% 2649
2021
Q1
$2.15M Sell
59,342
-4,816
-8% -$151K ﹤0.01% 2644
2020
Q4
$1.86M Buy
64,158
+987
+2% +$28.3K ﹤0.01% 2604
2020
Q3
$1.78M Buy
63,171
+280
+0.4% +$8.34K ﹤0.01% 2528
2020
Q2
$2.03M Buy
62,891
+4,469
+8% +$160K ﹤0.01% 2421
2020
Q1
$2.38M Sell
58,422
-40,371
-41% -$2.15M ﹤0.01% 2204
2019
Q4
$6.09M Buy
98,793
+1,080
+1% +$71.5K ﹤0.01% 1923
2019
Q3
$7.12M Sell
97,713
-3,916
-4% -$293K ﹤0.01% 1797
2019
Q2
$8.35M Sell
101,629
-21,264
-17% -$1.51M 0.01% 1712
2019
Q1
$8.67M Buy
122,893
+2,495
+2% +$147K 0.01% 1685
2018
Q4
$5.42M Buy
120,398
+14,593
+14% +$765K ﹤0.01% 1870
2018
Q3
$5.98M Buy
105,805
+22,229
+27% +$1.36M ﹤0.01% 1950
2018
Q2
$5.58M Buy
83,576
+21,700
+35% +$1.35M ﹤0.01% 1938
2018
Q1
$3.6M Sell
61,876
-2,785
-4% -$177K ﹤0.01% 2098
2017
Q4
$4.17M Buy
64,661
+17,920
+38% +$1.11M ﹤0.01% 2016
2017
Q3
$2.45M Buy
46,741
+4,313
+10% +$206K ﹤0.01% 2219
2017
Q2
$1.99M Buy
42,428
+3,522
+9% +$170K ﹤0.01% 2221
2017
Q1
$1.93M Buy
38,906
+10,489
+37% +$589K ﹤0.01% 2213
2016
Q4
$1.72M Buy
28,417
+1,540
+6% +$94.2K ﹤0.01% 2236
2016
Q3
$1.78M Buy
26,877
+13,377
+99% +$837K ﹤0.01% 2192
2016
Q2
$754K Hold
13,500
﹤0.01% 2440
2016
Q1
$455K Sell
13,500
-10,181
-43% -$345K ﹤0.01% 2615
2015
Q4
$1.07M Buy
23,681
+3,400
+17% +$146K ﹤0.01% 2364
2015
Q3
$802K Buy
20,281
+2,553
+14% +$145K ﹤0.01% 2455
2015
Q2
$1.1M Buy
17,728
+7,628
+76% +$454K ﹤0.01% 2378
2015
Q1
$632K Hold
10,100
﹤0.01% 2551
2014
Q4
$570K Hold
10,100
﹤0.01% 2568
2014
Q3
$286K Hold
10,100
﹤0.01% 2822
2014
Q2
$348K Buy
+10,100
New +$317K ﹤0.01% 2793

Other funds holding ANIP